ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q2 2021 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2021-08-16

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value: $51.74M (100.0% shares, 0.0% debt)

Holdings (2)

— MEDAVAIL HOLDINGS INC 92.0%

Value $47.6M Shares 3,885,951 Est. Cost $15.05 Unrealized —

LUNG PULMONX CORP 8.0%

Value $4.14M Shares 93,831 Est. Cost $48.97 Unrealized -11.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	3,885,951	$47.6M	92.0%	$15.05	—	COM	58406B103
LUNG	PULMONX CORP	93,831	$4.14M	8.0%	$48.97	-11.1%	COM	745848101